School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Zachary Buchwald

  • Department of Radiation Oncology
    Assistant Professor
  • zachary.scott.buchwald@emory.edu
  • Buchwald Lab
Head shot of Zachary Buchwald

Overview

A radiation oncologist and physician-scientist, Dr. Buchwald's primary clinical focus is radiation and immunotherapy for cutaneous malignancies.

Dr. Buchwald is actively involved in both basic and clinical research. In his laboratory, he studies ways to enhance the immune response against melanoma and other cancers using radiation. He is working to understand how different T-cell subsets are stimulated by radiation, the role of the tumor-draining lymph node in this process, and how to enhance this process with the goal of controlling disease in patients with locally advanced or metastatic cancer. Additionally, he studies ways to overcome steroid induced immuno-suppression of the anti-cancer immune response using focal, high dose radiation and combination checkpoint blockade. His lab is also focused on using radiation to modulate the immune response to viral infections and inflammatory diseases. He plans to continue translating these laboratory studies into clinical trials with the goal of improving long-term patient outcomes. Additionally, he has received multiple grants and awards including the ASCO Young Investigator Award, RSNA Resident Grant and an NIH K12 Grant.

Dr. Buchwald has been published in a number of leading journals including Immunity, Cancer, JCI Insight, and Scientific Reports.

Academic Appointment

  • Assistant Professor, Department of Radiation Oncology, Emory University School of Medicine

Education

Degrees

  • PhD from Saint Louis University
  • MD from Saint Louis University

Research

Publications

  • Combination radiation and PD-L1 enhance tumor control by stimulating CD8+PD-1+TCF-1+T cells in the tumor-draining lymph node.
    Nat Commun Volume: 16 Page(s): 3522
    04/14/2025 Authors: Shen Y; Connolly E; Aiello M; Zhou C; Chappa P; Song H; Tippitak P; Clark T; Cardenas M; Prokhnevska N
  • Skin Microbiome, Inflammation, and Skin Toxicities in Women With Breast Cancer Receiving Moderately Hypofractionated Radiation Therapy.
    Int J Radiat Oncol Biol Phys
    03/08/2025 Authors: Bai J; Gong C; Hu Y-J; Bruner DW; Torres MA; Buchwald ZS; Lin JY
  • Lymphatic vessel network injury reduces local tumor control despite preservation of the tumor-draining lymph node.
    Sci Rep Volume: 15 Page(s): 3485
    01/28/2025 Authors: Liebman LN; Shen Y; Buchwald ZS; Nepiyushchikh Z; Qi Z; Garca AJ; Dixon JB
  • Impact of race, ethnicity, and social determinants on outcomes following immune checkpoint therapy.
    J Immunother Cancer Volume: 12
    10/26/2024 Authors: Nayak RK; Aiello M; Maldonado LM; Clark TY; Buchwald ZS; Chang A
  • Pre-operative stereotactic radiosurgery and peri-operative dexamethasone for resectable brain metastases: a two-arm pilot study evaluating clinical outcomes and immunological correlates.
    Nat Commun Volume: 15 Page(s): 8854
    10/14/2024 Authors: Jansen CS; Pagadala MS; Cardenas MA; Prabhu RS; Goyal S; Zhou C; Chappa P; Vo BT; Ye C; Hopkins B
  • Drug's Journey of a Thousand Papers Begins With a Single Step.
    JCO Clin Cancer Inform Volume: 8 Page(s): e2400225
    10/01/2024 Authors: Innominato PF; Wreglesworth NI; Antonini A; Buchwald ZS
  • Pembrolizumab and low-dose, single-fraction radiotherapy for patients with relapsed or refractory multiple myeloma: a prospective, single-centre, single-group, open-label, phase 2 pilot trial in the USA.
    Lancet Haematol Volume: 11 Page(s): e510 - e520
    07/01/2024 Authors: Khan MK; Nasti TH; Qian JY; Kleber TJ; Switchenko JM; Kaufman JL; Nooka AJ; Dhodapkar MV; Buchwald ZS; Obiekwe D
  • Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade.
    Clin Cancer Res Volume: 30 Page(s): 1833 - 1845
    05/01/2024 Authors: Mariniello A; Nasti TH; Chang DY; Hashimoto M; Malik S; McManus DT; Lee J; McGuire DJ; Cardenas MA; Umana P
  • Total scalp irradiation: A study comparing multiple types of bolus and VMAT optimization techniques.
    J Appl Clin Med Phys Volume: 25 Page(s): e14260
    04/01/2024 Authors: Davis TM; Luca K; Sudmeier LJ; Buchwald ZS; Khan MK; Yang X; Schreibmann E; Zhang J; Roper J
  • Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis.
    J Immunother Cancer Volume: 12
    03/26/2024 Authors: Patel JS; Woo Y; Draper A; Jansen CS; Carlisle JW; Innominato PF; Lvi FA; Dhabaan L; Master VA; Bilen MA
  • Radiation and anti-PD-L1 synergize by stimulating a stem-like T cell population in the tumor-draining lymph node.
    Res Sq
    03/06/2024 Authors: Shen Y; Connolly E; Aiello M; Zhou C; Chappa P; Song H; Tippitak P; Clark T; Cardenas M; Prokhnevska N
  • SAMHD1 expression contributes to doxorubicin resistance and predicts survival outcomes in diffuse large B-cell lymphoma patients.
    NAR Cancer Volume: 6 Page(s): zcae007
    03/01/2024 Authors: Daddacha W; Monroe D; Schlafstein AJ; Withers AE; Thompson EB; Danelia D; Luong NC; Sesay F; Rath SK; Usoro ER
  • Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis.
    ESMO Open Volume: 9 Page(s): 102220
    02/01/2024 Authors: Landr T; Karabou A; Buchwald ZS; Innominato PF; Qian DC; Assi JB; Chouad C; Lvi F; Duchemann B
  • CD28-CD57+ T cells from head and neck cancer patients produce high levels of cytotoxic granules and type II interferon but are not senescent.
    Oncoimmunology Volume: 13 Page(s): 2367777
    01/01/2024 Authors: Kinney BLC; Brammer B; Kansal V; Parrish CJ; Kissick HT; Liu Y; Saba NF; Buchwald ZS; El-Deiry MW; Patel MR
  • The Deubiquitylase Otub1 Regulates the Chemotactic Response of Splenic B Cells by Modulating the Stability of the -Subunit Gng2.
    Mol Cell Biol Volume: 44 Page(s): 1 - 16
    01/01/2024 Authors: Luo VM; Shen C; Worme S; Bhagrath A; Simo-Cheyou E; Findlay S; Hbert S; Wai Lam Poon W; Aryanpour Z; Zhang T
  • The expanding role of IAP antagonists for the treatment of head and neck cancer.
    Cancer Med Volume: 12 Page(s): 13958 - 13965
    07/01/2023 Authors: Kansal V; Kinney BLC; Uppada S; Saba NF; Stokes WA; Buchwald ZS; Schmitt NC
  • Immune niches in brain metastases contain TCF1+ stem-like T cells, are associated with disease control and are modulated by preoperative SRS.
    Res Sq
    03/23/2023 Authors: Jansen CS; Prabhu RS; Pagadala MS; Chappa P; Goyal S; Zhou C; Neill SG; Prokhnevska N; Cardenas M; Hoang KB
  • Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models.
    J Immunother Cancer Volume: 11
    01/01/2023 Authors: Kansal V; Burnham AJ; Kinney BLC; Saba NF; Paulos C; Lesinski GB; Buchwald ZS; Schmitt NC
  • Immune checkpoint inhibitors and timing of administration - Authors' reply.
    Lancet Oncol Volume: 23 Page(s): e57
    02/01/2022 Authors: Qian DC; Buchwald ZS
  • Skin Microbiome and Treatment-Related Skin Toxicities in Patients With Cancer: A Mini-Review.
    Front Oncol Volume: 12 Page(s): 924849
    01/01/2022 Authors: Richardson BN; Lin J; Buchwald ZS; Bai J
  • Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study.
    Lancet Oncol Volume: 22 Page(s): 1777 - 1786
    12/01/2021 Authors: Qian DC; Kleber T; Brammer B; Xu KM; Switchenko JM; Janopaul-Naylor JR; Zhong J; Yushak ML; Harvey RD; Paulos CM
  • The Abscopal Effect: A Review of Pre-Clinical and Clinical Advances.
    Int J Mol Sci Volume: 22
    10/14/2021 Authors: Janopaul-Naylor JR; Shen Y; Qian DC; Buchwald ZS
  • Immunotherapeutic Strategies for Head and Neck Cancer.
    Otolaryngol Clin North Am Volume: 54 Page(s): 729 - 742
    08/01/2021 Authors: Buchwald ZS; Schmitt NC
  • An immunologic niche of antigen presenting cells and stem-like CD8+T-cells is present in non-small cell lung cancer brain metastases.
    Volume: 27
    04/01/2021 Authors: Jansen CS; del Balzo L; Prabhu R; Logan S; Chappa P; Patel K; Wilkinson S; Lake R; Shu H-KG; Zhong J
  • Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with Coronavirus Disease 2019-Related Pneumonia.
    Int J Radiat Oncol Biol Phys Volume: 109 Page(s): 867 - 879
    03/15/2021 Authors: Hess CB; Nasti TH; Dhere VR; Kleber TJ; Switchenko JM; Buchwald ZS; Stokes WA; Weinberg BD; Rouphael N; Steinberg JP
  • Leptomeningeal disease and neurologic death after surgical resection and radiosurgery for brain metastases: A multi-institutional analysis.
    Adv Radiat Oncol Volume: 6 Page(s): 100644
    01/01/2021 Authors: Prabhu RS; Turner BE; Asher AL; Marcrom SR; Fiveash JB; Foreman PM; Press RH; Buchwald ZS; Curran WJ; Patel KR
  • The Association Between Radiation Therapy Dose and Overall Survival in Patients With Intracranial Infiltrative Low-Grade Glioma Treated With Concurrent and/or Adjuvant Chemotherapy.
    Adv Radiat Oncol Volume: 6 Page(s): 100577
    01/01/2021 Authors: Prabhu RS; Ward MC; Heinzerling JH; Corso CD; Buchwald ZS; Dhakal R; Asher AL; Sumrall AL; Burri SH
  • Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with COVID-19-Related Pneumonia.
    Int J Radiat Oncol Biol Phys Volume: 108 Page(s): 1401
    12/01/2020 Authors: Hess CB; Buchwald ZS; Stokes WA; Nasti T; Switchenko J; Weinberg BD; Rouphael N; Steinberg JP; Godette KD; Murphy DJ
  • Low-dose whole-lung radiation for COVID-19 pneumonia: Planned day 7 interim analysis of a registered clinical trial.
    Cancer Volume: 126 Page(s): 5109 - 5113
    12/01/2020 Authors: Hess CB; Buchwald ZS; Stokes W; Nasti TH; Switchenko JM; Weinberg BD; Steinberg JP; Godette KD; Murphy D; Ahmed R
  • Proton Radiation Is Associated With Reduced Lymphocyte-Depleting Blood Volume In Glioblastoma Treatment
    Volume: 108 Page(s): E688 - E689
    11/01/2020 Authors: Buchwald ZS; Dang Q; Zhou J; Eaton BR; Shu HKG; Zhong J
  • Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy.
    J Immunother Cancer Volume: 8
    10/01/2020 Authors: Buchwald ZS; Nasti TH; Lee J; Eberhardt CS; Wieland A; Im SJ; Lawson D; Curran W; Ahmed R; Khan MK
  • Low-dose whole-lung radiation for COVID-19 pneumonia: Planned day-7 interim analysis of a registered clinical trial.
    Volume: 26
    09/01/2020 Authors: Hess CB; Buchwald ZS; Stokes W; Nasti TH; Switchenko JM; Weinberg BD; Steinberg JP; Godette KD; Murphy D; Ahmed R
  • Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity Analysis.
    Int J Radiat Oncol Biol Phys Volume: 108 Page(s): 304 - 313
    09/01/2020 Authors: Tian S; Switchenko JM; Buchwald ZS; Patel PR; Shelton JW; Kahn SE; Pillai RN; Steuer CE; Owonikoko TK; Behera M
  • Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification.
    Cancer Volume: 126 Page(s): 3255 - 3264
    07/15/2020 Authors: Press RH; Shafer SL; Jiang R; Buchwald ZS; Abugideiri M; Tian S; Morgan TM; Behera M; Sengupta S; Voloschin AD
  • The effect of adjuvant radiotherapy on overall survival in adults with intracranial ependymoma.
    Neurooncol Pract Volume: 7 Page(s): 391 - 399
    07/01/2020 Authors: Prabhu RS; Corso CD; Ward MC; Heinzerling JH; Dhakal R; Buchwald ZS; Patel KR; Asher AL; Sumrall AL; Burri SH
  • Leptomeningeal disease after surgical resection and radiosurgery for brain metastases and neurologic death: A multi-institutional analysis.
    Volume: 38
    05/20/2020 Authors: Prabhu RS; Turner BE; Asher AL; Marcrom S; Fiveash JB; Foreman PM; Press RH; Buchwald Z; Curran WJ; Patel KR
  • Genomic copy number variation correlates with survival outcomes in WHO grade IV glioma.
    Sci Rep Volume: 10 Page(s): 7355
    04/30/2020 Authors: Buchwald ZS; Tian S; Rossi M; Smith GH; Switchenko J; Hauenstein JE; Moreno CS; Press RH; Prabhu RS; Zhong J
  • Moderately Hypofractionated Radiation for Benign Meningiomas and Schwannomas: A Report of 70 Patients Treated Between 2008 and 2018.
    Adv Radiat Oncol Volume: 5 Page(s): 1147 - 1151
    01/01/2020 Authors: Dhere VR; Tian S; Buchwald Z; Jiang X; Zhang C; Chen Z; Eaton BR; Shu H-KG; Curran WJ; Zhong J
  • Complete and Durable Response After Radiation Therapy to Primary Tumor Site of a Patient With Metastatic Anorectal Mucosal Melanoma With Oligoprogression on Nivolumab.
    Adv Radiat Oncol Volume: 5 Page(s): 503 - 510
    01/01/2020 Authors: Wallington DG; Rashid AS; Buchwald ZS; Sudmeier LJ; Khan MK
  • Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain Metastases.
    Pract Radiat Oncol Volume: 10 Page(s): 36 - 43
    01/01/2020 Authors: Tanenbaum DG; Buchwald ZS; Jhaveri J; Schreibmann E; Switchenko JM; Prabhu RS; Chowdhary M; Abugideiri M; Pfister NT; Eaton B
  • Reduced-volume tumor-bed boost is not associated with inferior local control and survival outcomes in high-risk medulloblastoma.
    Pediatr Blood Cancer Volume: 67 Page(s): e28027
    01/01/2020 Authors: Tian S; Sudmeier LJ; Zhang C; Madden NA; Buchwald ZS; Shu H-KG; Curran WJ; Eaton BR; Esiashvili N
  • Survival outcomes in patients with gastric and gastroesophageal junction adenocarcinomas treated with perioperative chemotherapy with or without preoperative radiotherapy.
    Cancer Volume: 126 Page(s): 37 - 45
    01/01/2020 Authors: Tian S; Jiang R; Madden NA; Ferris MJ; Buchwald ZS; Xu KM; Cardona K; Maithel SK; McDonald MW; Lin JY
  • The Effect of Dexamethasone on the Apd-1/L1 and Radiotherapy Stimulated Anti-Tumor Response
    Volume: 105 Page(s): S122 - S123
    09/01/2019 Authors: Buchwald ZS; Nasti T; Wieland A; Hudson W; Valanparambil R; Eberhardt C; Lawson D; Lin JY; Curran WJ; Ahmed R
  • Impact of Glucocorticoids on the Gut Microbiome with or without Anti-PD-L1
    Volume: 105 Page(s): E667 - E667
    09/01/2019 Authors: Tsementzi D; Buchwald ZS; Qiu L; Khan MK; Konstantinidis K; Bruner DW; Lin JY
  • Hypofractionated Radiation for Benign Meningiomas and Vestibular Schwannomas
    Volume: 105 Page(s): E97 - E97
    09/01/2019 Authors: Dhere VR; Sudmeier LJ; Buchwald ZS; Tian S; Jiang X; Zhang C; Chen Z; Eaton BR; Shu HKG; Crocker IR
  • Tumor-draining lymph node irradiation reduces tumor-infiltrating stem-like CD8(+)T-cells and abrogates the abscopal effect
    Volume: 79
    07/01/2019 Authors: Buchwald ZS; Nasti TH; Eberhardt CS; Wieland A; Lawson D; Curran W; Ahmed R; Khan MK
  • The timing of chemoradiotherapy after surgical resection and its impact on overall survival in glioblastoma.
    Volume: 37
    05/20/2019 Authors: Press RH; Shafer SL; Jiang R; Buchwald ZS; Abugideiri M; Tian S; Morgan T; Behera M; Sengupta S; Voloschin AD
  • Repurposing Drugs for Cancer Radiotherapy: Early Successes and Emerging Opportunities.
    Cancer J Volume: 25 Page(s): 106 - 115
    01/01/2019 Authors: Khan MK; Nasti TH; Buchwald ZS; Weichselbaum RR; Kron SJ
  • Neoadjuvant therapy of locally/regionally advanced melanoma.
    Ther Adv Med Oncol Volume: 11 Page(s): 1758835919866959
    01/01/2019 Authors: Khunger A; Buchwald ZS; Lowe M; Khan MK; Delman KA; Tarhini AA
  • CLINICAL AND DOSIMETRIC FACTORS RELATED TO RADIATION NECROSIS AFTER FIVE FRACTION RADIOSURGERY FOR RESECTED BRAIN METASTASES
    Volume: 20 Page(s): 54 - 54
    11/01/2018 Authors: Buchwald Z; Jhaveri J; Schreibmann E; Switchenko J; Prabhu R; Chowdhary M; Abugideiri M; Eaton B; Olson J; Shu H-K
  • Reduced-Volume Tumor Bed Boost is Not Associated with Inferior Local Control and Survival Outcomes in High-Risk Medulloblastoma
    Volume: 102 Page(s): E468 - E469
    11/01/2018 Authors: Sudmeier LJ; Tian S; Zhang C; Madden NA; Buchwald ZS; Eaton BR; Shu HKG; Crocker IR; Curran WJ; Esiashvili N
  • Report of Neurotoxicity after Concurrent Whole Brain Radiation Therapy and Checkpoint Blockade Immunotherapy for Patients with Brain Metastases
    Volume: 102 Page(s): E340 - E340
    11/01/2018 Authors: Press RH; Buchwald ZS; Steuer C; Pillai R; Owonikoko TK; Ramalingam S; Curran WJ; Higgins KA
  • Pre- vs Post-Operative Radiation Therapy, and Time to Surgery: An Exploratory Analysis of Predictors of Survival in Soft Tissue Sarcoma Stratified by Histological Subtype
    Volume: 102 Page(s): E206 - E206
    11/01/2018 Authors: Buchwald ZS; Fortune C; Zhang C; Abugideiri M; Jhaveri J; Press RH; Morgan T; Tian S; Yushak M; Godette KD
  • Outcomes and Practice Patterns for Aggressive Local Therapy in Newly Diagnosed Stage IV Soft Tissue Sarcoma: An NCDB Analysis
    Volume: 102 Page(s): E228 - E229
    11/01/2018 Authors: Abugideiri M; Switchenko J; Tian S; Madden NA; Press RH; Buchwald ZS; Zhong J; Jhaveri J; Ferris MJ; Behera M
  • Improving Reproducibility and Inter-Rater Reliability for Lumpectomy Cavity Boost Contouring in Breast Cancer Patients Using a 3-D Bio-Absorbable Tissue Marker
    Volume: 102 Page(s): E580 - E580
    11/01/2018 Authors: Abugideiri M; Press RH; Zhang C; Thomas M; Tian S; Jhaveri J; Cassidy RJ; Zaenger D; Morgan T; Madden NA
  • Exosomes, Their Biogenesis and Role in Inter-Cellular Communication, Tumor Microenvironment and Cancer Immunotherapy.
    Vaccines (Basel) Volume: 6
    09/26/2018 Authors: Jella KK; Nasti TH; Li Z; Malla SR; Buchwald ZS; Khan MK
  • Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery.
    J Neurooncol Volume: 139 Page(s): 689 - 697
    09/01/2018 Authors: Chowdhary M; Switchenko JM; Press RH; Jhaveri J; Buchwald ZS; Blumenfeld PA; Marwaha G; Diaz A; Wang D; Abrams RA
  • Survival outcomes in gastric and gastroesophageal junction adenocarcinoma treated with peri-operative chemotherapy with or without pre-operative radiotherapy.
    Volume: 36
    05/20/2018 Authors: Tian S; Jiang R; Madden NA; Ferris MJ; Buchwald Z; Xu KM; Cardona K; Maithel S; McDonald MW; Lin JY
  • Correlation of genomic copy number variation with survival outcomes in high-grade glioma patients
    Volume: 36
    05/20/2018 Authors: Buchwald Z; Rossi MR; Smith G; Switchenko JM; Hauenstein J; Zhong J; Press RH; Tian S; Saxe D; Neill S
  • Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base.
    Cancer Volume: 124 Page(s): 1169 - 1178
    03/15/2018 Authors: Jhaveri J; Liu Y; Chowdhary M; Buchwald ZS; Gillespie TW; Olson JJ; Voloschin AD; Eaton BR; Shu H-KG; Crocker IR
  • Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation.
    Front Oncol Volume: 8 Page(s): 612
    01/01/2018 Authors: Buchwald ZS; Wynne J; Nasti TH; Zhu S; Mourad WF; Yan W; Gupta S; Khleif SN; Khan MK
  • Proton vs. Photon Radiation Therapy for Primary Gliomas: An Analysis of the National Cancer Data Base.
    Front Oncol Volume: 8 Page(s): 440
    01/01/2018 Authors: Jhaveri J; Cheng E; Tian S; Buchwald Z; Chowdhary M; Liu Y; Gillespie TW; Olson JJ; Diaz AZ; Voloschin A
  • Increase in PD-L1 expression after pre-operative radiotherapy for soft tissue sarcoma.
    Oncoimmunology Volume: 7 Page(s): e1442168
    01/01/2018 Authors: Patel KR; Martinez A; Stahl JM; Logan SJ; Perricone AJ; Ferris MJ; Buchwald ZS; Chowdhary M; Delman KA; Monson DK
  • Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery.
    J Neurooncol Volume: 136 Page(s): 289 - 298
    01/01/2018 Authors: Chowdhary M; Okwan-Duodu D; Switchenko JM; Press RH; Jhaveri J; Buchwald ZS; Zhong J; Chapman BV; Bindra RS; Contessa JN
  • Truth in Advertising: Do Clinical Trial Publications Tell It All?
    J Natl Compr Canc Netw Volume: 15 Page(s): 1439 - 1440
    11/01/2017 Authors: Khan MK; Buchwald ZS; Mourad WF
  • Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
    Int J Radiat Oncol Biol Phys Volume: 99 Page(s): 459 - 467
    10/01/2017 Authors: Prabhu RS; Press RH; Patel KR; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE
  • Matrix metalloproteinases: their functional role in lung cancer.
    Carcinogenesis Volume: 38 Page(s): 766 - 780
    08/01/2017 Authors: Merchant N; Nagaraju GP; Rajitha B; Lammata S; Jella KK; Buchwald ZS; Lakka SS; Ali AN
  • Is less more? Comparing chemotherapy alone to chemotherapy and radiation for high risk, grade II glioma-An analysis of the National Cancer Data Base.
    Volume: 35
    05/20/2017 Authors: Jhaveri J; Liu Y; Gillespie TW; Chowdhary M; Buchwald Z; Olson JJ; Voloschin AD; Shu H-KG; Crocker IR; Curran WJ
  • Postoperative stereotactic radiosurgery for resected brain metastases: A comparison of outcomes for large resection cavities.
    Pract Radiat Oncol Volume: 7 Page(s): e419 - e425
    01/01/2017 Authors: Zhong J; Ferris MJ; Switchenko J; Press RH; Buchwald Z; Olson JJ; Eaton BR; Curran WJ; Shu H-KG; Crocker IR
  • Adjuvant Radiation Therapy Improved Local Control for Primary Mucosal Melanoma of the Head and Neck
    Volume: 96 Page(s): E384 - E385
    10/01/2016 Authors: Abugideiri M; Patel K; Switchenko JM; Magliocca K; Buchwald ZS; Delgaudio J; Lawson DH; Danish H; Beitler JJ; Khan MK
  • Genomic Copy Number Complexity Correlates With Overall Survival in Glioblastoma Patients
    Volume: 96 Page(s): S92 - S93
    10/01/2016 Authors: Buchwald ZS; Rossi M; Smith G; Abugideiri M; Hauenstein JE; Saxe DF; Neill SG; Ali AN; Brat DJ; Olson JJ
  • Genomic Copy Number Complexity Correlates With Overall Survival in Glioblastoma Patients
    Volume: 96 Page(s): S92 - S93
    10/01/2016 Authors: Buchwald ZS; Rossi M; Smith G; Abugideiri M; Hauenstein JE; Saxe DF; Neill SG; Ali AN; Brat DJ; Olson JJ
  • Adjuvant Radiation Therapy Improved Local Control for Primary Mucosal Melanoma of the Head and Neck
    Volume: 96 Page(s): E384 - E385
    10/01/2016 Authors: Abugideiri M; Patel K; Switchenko JM; Magliocca K; Buchwald ZS; Delgaudio J; Lawson DH; Danish H; Beitler JJ; Khan MK
  • Genomic Copy Number Complexity Correlates With Overall Survival in Glioblastoma Patients.
    Volume: 96 Page(s): S92 - S93
    10/01/2016 Authors: Buchwald ZS; Rossi M; Smith G; Abugideiri M; Hauenstein JE; Saxe DF; Neill SG; Ali AN; Brat DJ; Olson JJ
  • Adjuvant Radiation Therapy Improved Local Control for Primary Mucosal Melanoma of the Head and Neck.
    Int J Radiat Oncol Biol Phys Volume: 96 Page(s): E384 - E385
    10/01/2016 Authors: Abugideiri M; Patel K; Switchenko JM; Magliocca K; Buchwald ZS; Delgaudio J; Lawson DH; Danish H; Beitler JJ; Khan MK
  • Osteoclast-Primed Foxp3+ CD8 T Cells Induce T-bet, Eomesodermin, and IFN- To Regulate Bone Resorption.
    J Immunol Volume: 197 Page(s): 726 - 735
    08/01/2016 Authors: Shashkova EV; Trivedi J; Cline-Smith AB; Ferris C; Buchwald ZS; Gibbs J; Novack D; Aurora R
  • A Bone Anabolic Effect of RANKL in a Murine Model of Osteoporosis Mediated Through FoxP3+ CD8 T Cells.
    J Bone Miner Res Volume: 30 Page(s): 1508 - 1522
    08/01/2015 Authors: Buchwald ZS; Yang C; Nellore S; Shashkova EV; Davis JL; Cline A; Ko J; Novack DV; DiPaolo R; Aurora R
  • Words of wisdom. Re: MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer.
    Eur Urol Volume: 67 Page(s): 975
    05/01/2015 Authors: Buchwald ZS; Efstathiou JA
  • Patients with pediatric obstructive sleep apnea show altered T-cell populations with a dominant TH17 profile.
    Otolaryngol Head Neck Surg Volume: 150 Page(s): 880 - 886
    05/01/2014 Authors: Anderson ME; Buchwald ZS; Ko J; Aurora R; Sanford T
  • Osteoclast-induced Foxp3+ CD8 T-cells limit bone loss in mice.
    Bone Volume: 56 Page(s): 163 - 173
    09/01/2013 Authors: Buchwald ZS; Kiesel JR; Yang C; DiPaolo R; Novack DV; Aurora R
  • Osteoclasts and CD8 T cells form a negative feedback loop that contributes to homeostasis of both the skeletal and immune systems.
    Clin Dev Immunol Volume: 2013 Page(s): 429373
    01/01/2013 Authors: Buchwald ZS; Aurora R
  • RAE1 ligand expressed on pancreatic islets recruits NKG2D receptor-expressing cytotoxic T cells independent of T cell receptor recognition.
    Immunity Volume: 36 Page(s): 132 - 141
    01/27/2012 Authors: Markiewicz MA; Wise EL; Buchwald ZS; Pinto AK; Zafirova B; Polic B; Shaw AS
  • Osteoclast activated FoxP3+ CD8+ T-cells suppress bone resorption in vitro.
    PLoS One Volume: 7 Page(s): e38199
    01/01/2012 Authors: Buchwald ZS; Kiesel JR; DiPaolo R; Pagadala MS; Aurora R
  • Cross-presentation by osteoclasts induces FoxP3 in CD8+ T cells.
    J Immunol Volume: 182 Page(s): 5477 - 5487
    05/01/2009 Authors: Kiesel JR; Buchwald ZS; Aurora R
  • IL-12 enhances CTL synapse formation and induces self-reactivity.
    J Immunol Volume: 182 Page(s): 1351 - 1361
    02/01/2009 Authors: Markiewicz MA; Wise EL; Buchwald ZS; Cheney EE; Hansen TH; Suri A; Cemerski S; Allen PM; Shaw AS
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements